Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-16

FDA Approved: ELAPRASE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Elaprase (idursulfase) by Takeda Pharmaceuticals America, Inc., related to changes or additions to the product l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Elaprase (idursulfase)

Snippet

SUPPL AP for ELAPRASE (IDURSULFASE)